Drug recall · June 29, 2016
Mycophenolate Mofetil recall
Why: cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada
- Lots / codes
Lot Number: A3160A, Manufacturer batch number: 151201, Expiry November 2017
- Quantity
- N/A
- Company
- Attix Pharmaceuticals Inc, Toronto, N/A
- Distribution
- CO
- Initiated
- May 18, 2016 · Voluntary: Firm initiated
- Classified
- June 21, 2016
- Reported
- June 29, 2016
- Ended
- July 26, 2016
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Mycophenolate mofetil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.